Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Ligand Pharmaceuticals (LGND) Short Interest Ratio & Short Volume

Ligand Pharmaceuticals logo
$220.56 +2.82 (+1.29%)
As of 02:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Ligand Pharmaceuticals Short Interest Overview

As of April 30, 2026, Ligand Pharmaceuticals (LGND) had a short interest of 1.46 million shares sold short, representing 7.81% of the public float. This marks a 3.44% increase in short interest since the prior report. The short interest ratio (days to cover) is 8.0, meaning it would take 8.0 days of the average trading volume of 222,449 shares to cover all short positions.

Current Short Interest
1,455,087 shares
Previous Short Interest
1,406,701 shares
Change Vs. Previous Month
3.44%
Dollar Volume Sold Short
$333.87 million
Short Interest Ratio
8.0 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
20,040,000 shares
Short Percent of Float
7.81%
Today's Trading Volume
65,270 shares
Average Trading Volume
222,449 shares
Today's Volume Vs. Average
29%
Short Selling Ligand Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LGND Short Interest Over Time

LGND Days to Cover Over Time

LGND Percentage of Float Shorted Over Time

Ligand Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20261,455,087 shares $333.87 million +3.4%7.8%7.97 $229.45
4/15/20261,406,701 shares $316.63 million -5.9%7.6%5.26 $225.09
3/31/20261,495,607 shares $298.60 million +2.5%8.1%6.45 $199.65
3/13/20261,458,857 shares $296.02 million +5.9%7.9%5.76 $202.91
2/27/20261,378,177 shares $273.31 million +0.5%7.4%9.02 $198.31
2/13/20261,371,498 shares $252.12 million +6.9%7.5%6.93 $183.83
1/30/20261,283,046 shares $246.47 million +1.2%7.0%6.49 $192.10
1/15/20261,267,548 shares $248.54 million +1.7%6.9%4.55 $196.08
12/31/20251,246,230 shares $235.62 million +13.7%6.8%6.81 $189.07
12/15/20251,095,980 shares $211.39 million -1.2%6.0%4.77 $192.88
11/28/20251,108,765 shares $225.24 million +5.6%6.1%4.81 $203.15
11/14/20251,050,284 shares $210.96 million -5.2%5.8%4.24 $200.86
10/31/20251,107,928 shares $211.96 million -6.2%6.1%7.24 $191.31
10/15/20251,180,000 shares $216.29 million -1.7%6.5%5.4 $183.30
9/30/20251,200,000 shares $212.57 million +7.1%N/A5 $177.14
9/15/20251,120,000 shares $185.37 million -3.5%N/A4.7 $165.51
8/31/20251,160,000 shares $187.58 million -2.5%6.4%5.5 $161.71
8/15/20251,190,000 shares $179.79 million +29.9%N/A5.8 $151.08
7/31/2025915,900 shares $120.51 million -25.5%5.1%5.4 $131.58
7/15/20251,230,000 shares $152.89 million +3.4%N/A8.7 $124.30
6/30/20251,190,000 shares $135.28 million +3.5%6.6%9.7 $113.68
6/15/20251,150,000 shares $129.38 million -6.5%6.4%9.7 $112.50
5/31/20251,230,000 shares $126.90 million +12.8%6.9%10.2 $103.17
5/15/20251,090,000 shares $112.78 million -10.7%6.1%8.9 $103.47
4/30/20251,220,000 shares $134.03 million +7.0%N/A10.2 $109.86
4/15/20251,140,000 shares $121.75 million +12.9%6.4%10.1 $106.80
3/31/20251,010,000 shares $106.19 million +5.8%5.7%9 $105.14
3/15/2025955,100 shares $101.42 million +22.4%5.4%8.3 $106.19
2/28/2025780,100 shares $95.35 million -7.7%4.4%7.1 $122.23
2/15/2025845,000 shares $101.40 million -11.2%4.8%8 $120.00
1/31/2025951,500 shares $110.90 million +4.4%N/A8.2 $116.55
1/15/2025911,400 shares $100.51 million +1.3%N/A7.4 $110.28
12/31/2024900,100 shares $96.45 million +10.7%N/A7.5 $107.15
12/15/2024812,800 shares $95.02 million +3.5%N/A6.9 $116.91
11/30/2024785,700 shares $95.44 million -5.5%N/A7.1 $121.47
11/15/2024831,500 shares $92.89 million -9.5%N/A7.5 $111.71
10/31/2024918,600 shares $97.10 million -8.1%N/A8.5 $105.70
10/15/20241,000,000 shares $104.39 million +0.4%N/A9.5 $104.39
9/30/2024996,100 shares $99.70 million +1.9%N/A8.7 $100.09
9/15/2024977,400 shares $102.40 million -1.8%N/A7.9 $104.77
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel

Click here to watch this short 3-minute video now.
8/31/2024995,000 shares $105.27 million -6.1%N/A8.1 $105.80
8/15/20241,060,000 shares $109.32 million +10.3%N/A8.3 $103.13
7/31/2024960,700 shares $104.71 million -12.7%N/A6.9 $108.99
7/15/20241,100,000 shares $106.34 million +17.7%N/A7.9 $96.67
6/30/2024934,400 shares $78.73 million -0.2%N/A6.5 $84.26
6/15/2024936,600 shares $74.98 million +32.3%N/A6.6 $80.06
5/31/2024707,700 shares $60.19 million -17.6%N/A4.3 $85.05
5/15/2024858,700 shares $73.65 million +7.9%N/A4.6 $85.77
4/30/2024795,600 shares $55.60 million -3.8%N/A4.3 $69.89
4/15/2024826,600 shares $65.94 million +23.0%5.0%4.9 $79.77
3/31/2024672,100 shares $49.13 million -23.3%4.1%4.1 $73.10
3/15/2024876,300 shares $62.30 million +14.9%5.3%5.8 $71.09
2/29/2024762,600 shares $60.51 million -15.0%4.6%5.3 $79.35
2/15/2024896,600 shares $66.93 million -3.6%5.5%7.3 $74.65
1/31/2024929,800 shares $67.97 million +1.0%5.7%8.1 $73.10
1/15/2024920,700 shares $66.84 million +2.2%6.9%8.2 $72.60
12/31/2023900,800 shares $64.34 million +0.8%5.5%8.2 $71.42
12/15/2023893,600 shares $60.18 million -1.7%5.5%8.1 $67.35
11/30/2023909,100 shares $53.01 million -2.3%5.5%8.8 $58.31
11/15/2023930,200 shares $52.54 million +6.1%5.7%9.2 $56.48
10/31/2023876,400 shares $45.83 million +3.8%5.4%8.8 $52.29
10/15/2023844,700 shares $46.45 million +2.5%5.2%8.8 $54.99
9/30/2023824,100 shares $49.38 million -0.1%5.1%8.4 $59.92
9/15/2023825,000 shares $51.13 million -6.2%5.1%8.8 $61.98
8/31/2023879,200 shares $57.82 million +4.6%5.4%9.1 $65.77
8/15/2023840,500 shares $56.81 million +4.3%5.2%8.6 $67.59
7/31/2023805,800 shares $53.93 million -3.4%5.0%8.2 $66.93
7/15/2023834,300 shares $56.61 million -1.4%5.1%8.4 $67.85
6/30/2023846,200 shares $61.01 million +4.0%5.2%8.6 $72.10
6/15/2023814,000 shares $64.30 million -1.6%5.0%7.8 $78.99
5/31/2023827,100 shares $57.96 million +1.3%5.1%7.9 $70.08
5/15/2023816,400 shares $63.34 million +0.7%5.0%7.2 $77.59
4/30/2023811,100 shares $61.93 million +5.1%5.1%7 $76.35
4/15/2023771,800 shares $57.38 million -1.0%4.8%6.6 $74.34
3/31/2023779,200 shares $57.32 million -13.5%4.9%6.5 $73.56
3/15/2023900,500 shares $64.48 million +7.5%5.6%7.1 $71.61
2/28/2023838,100 shares $60.46 million +2.5%5.2%5.1 $72.14
2/15/2023817,900 shares $59.69 million +1.5%5.1%4.8 $72.98
1/31/2023806,000 shares $56.18 million +0.1%5.1%4.6 $69.70
1/15/2023805,000 shares $57.38 million +1.5%5.1%4.1 $71.28
12/30/2022792,800 shares $52.96 million -8.4%5.0%4.1 $66.80
12/15/2022865,800 shares $53.81 million +13.0%5.5%4.4 $62.15
11/30/2022766,100 shares $55.85 million -2.3%4.8%4.6 $72.90
11/15/2022784,100 shares $61.99 million +6.6%4.9%5 $79.06
10/31/2022735,400 shares $64.46 million -0.3%4.6%5 $87.65
10/15/2022737,800 shares $66.03 million -6.7%4.6%6 $89.49
9/30/2022790,600 shares $68.08 million -5.1%5.0%6.6 $86.11
9/15/2022833,000 shares $75.08 million +3.1%5.2%7 $90.13
8/31/2022808,200 shares $74.67 million -3.7%5.1%6.6 $92.39
8/15/2022839,000 shares $90.03 million -3.2%5.3%6.8 $107.31
Elon Musk’s $1 Quadrillion AI IPO (Ad)

$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.tc pixel

Claim Your Stake Now
7/31/2022866,700 shares $79.76 million -0.8%5.4%6.5 $92.03
7/15/2022873,600 shares $82.58 million -3.6%5.4%6 $94.53
6/30/2022905,800 shares $80.82 million -0.2%5.6%6 $89.22
6/15/2022907,900 shares $71.80 million -0.6%N/A5.7 $79.08
5/31/2022913,400 shares $81.21 million -10.5%5.7%6.2 $88.91
5/15/20221,020,000 shares $87.68 million -8.9%6.4%6.2 $85.96
4/30/20221,120,000 shares $104.00 million No Change7.0%6.8 $92.86
4/15/20221,120,000 shares $117.89 million -8.9%7.0%6.8 $105.26
3/31/20221,230,000 shares $138.36 million +2.5%7.7%7.2 $112.49
3/15/20221,200,000 shares $125.44 million -2.4%7.5%7.5 $104.53
2/28/20221,230,000 shares $124.50 million No Change7.7%7.7 $101.22
2/15/20221,230,000 shares $152.13 million -10.2%7.8%8.1 $123.68
1/31/20221,370,000 shares $170.74 million -11.0%8.6%9.7 $124.63
1/15/20221,540,000 shares $192.36 million -4.4%9.7%11.3 $124.91
12/31/20211,610,000 shares $248.68 million -4.2%10.1%13.4 $154.46
12/15/20211,680,000 shares $247.80 million +5.0%10.6%13.9 $147.50
11/30/20211,600,000 shares $259.07 million +0.6%10.1%13.5 $161.92
11/15/20211,590,000 shares $260.93 million -4.2%10.0%8 $164.11
10/29/20211,660,000 shares $242.26 million No Change10.5%8 $145.94
10/15/20211,660,000 shares $216.23 million -4.1%10.5%7.9 $130.26
9/30/20211,730,000 shares $241.02 million -2.8%10.9%8 $139.32
9/15/20211,780,000 shares $241.83 million +10.6%11.2%7.8 $135.86
8/31/20211,610,000 shares $213.00 million -0.6%10.2%7 $132.30
8/13/20211,620,000 shares $173.05 million -1.8%10.2%10.1 $106.82
7/30/20211,650,000 shares $187.29 million -6.3%10.4%11 $113.51
7/15/20211,760,000 shares $203.84 million +0.6%11.1%11.7 $115.82
6/30/20211,750,000 shares $229.58 million +1.7%11.0%11.7 $131.19
6/15/20211,720,000 shares $212.97 million +8.2%10.8%12 $123.82
5/28/20211,590,000 shares $187.14 million -0.6%10.0%9.8 $117.70

LGND Short Interest - Frequently Asked Questions

Short interest is the volume of Ligand Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,455,087 shares of LGND short. 7.81% of Ligand Pharmaceuticals' shares are currently sold short. Learn More on Ligand Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LGND shares currently have a short interest ratio of 8.0. Learn More on Ligand Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.81% of Ligand Pharmaceuticals' floating shares are currently sold short.

Ligand Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,455,087 shares, an increase of 3.4% from the previous total of 1,406,701 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.81% of Ligand Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Ligand Pharmaceuticals: ADMA Biologics Inc (9.03%), ANI Pharmaceuticals, Inc. (17.30%), Neurocrine Biosciences, Inc. (6.25%), Exelixis, Inc. (12.26%), Ionis Pharmaceuticals, Inc. (10.13%), Madrigal Pharmaceuticals, Inc. (20.29%), BioMarin Pharmaceutical Inc. (5.63%), Halozyme Therapeutics, Inc. (12.45%), Alkermes plc (12.43%), Repligen Corporation (9.81%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling LGND is an investing strategy that aims to generate trading profit from Ligand Pharmaceuticals as its price is falling. LGND shares are trading up $9.97 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ligand Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LGND, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LGND, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LGND:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:LGND) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel